BioSpace News Archive

Press Releases

March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma

January 28, 2025
·
3 min read
Press Releases

Humacyte and Pluristyx Announce Gene Editing Partnership to Support BioVascular Pancreas (BVP™) Development Using iPSCs

January 28, 2025
·
6 min read
Press Releases

INmune Bio Inc. Expands INKmune Trial in Prostate Cancer to Veterans

January 28, 2025
·
7 min read
Press Releases

Saol Therapeutics announces FDA acceptance of New Drug Application for SL1009 for treatment of Pyruvate Dehydrogenase Complex Deficiency

January 28, 2025
·
3 min read
Press Releases

Eterna Therapeutics Announces Expansion of Scientific Advisory Board

January 28, 2025
·
4 min read
Press Releases

Neurocrine Biosciences Announces Initiation of Phase 3 Registrational Program for Osavampator as an Adjunctive Therapy for the Treatment of Major Depressive Disorder in Adults

January 28, 2025
·
5 min read
Press Releases

Tris Pharma Reports Positive Clinical Results of Intranasal Human Abuse Potential Study Indicating Low Abusability of Cebranopadol, an Investigational, First-in-Class Oral Dual-NMR Agonist for the Treatment of Moderate-to-Severe Pain

January 28, 2025
·
7 min read
Press Releases

Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering

January 28, 2025
·
6 min read
Press Releases

Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery from Plasmid to Structure

January 28, 2025
·
3 min read
Press Releases

SEED Receives FDA Rare Pediatric Disease and Orphan Drug Designations for Lead Oncology Asset RBM39 Degrader and Enters Strategic Transactions with New Investors

January 28, 2025
·
3 min read